Mofegiline
Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
Grundinformationen
- CAS
119386-96-8- Standard-SMILES
NC/C(=C/F)CCc1ccc(F)cc1- InChIKey
VXLBSYHAEKDUSU-JXMROGBWSA-N- Summenformel
- C11H13F2N
- Durchschnittliche Molmasse
- 197,22 g/mol
- Monoisotopische Masse
- 197,10160586
Überblick
Mofegiline is a small molecule drug. The usage of the INN stem '-giline' in the name indicates that Mofegiline is a monoamine oxydase (MAO)-inhibitor type B. Mofegiline has a monoisotopic molecular weight of 197.1 Da.
Namen und Bezeichner
- Bevorzugter Name
- Mofegiline
- IUPAC
- (2E)-2-(fluoromethylidene)-4-(4-fluorophenyl)butan-1-amine
- Englischer Name
- Mofegiline
- Summenformel
- C11H13F2N
- Molmasse
- 197.22
Namen und Synonyme
Mofegiline119386-96-8mofegilina(2E)-2-(fluoromethylidene)-4-(4-fluorophenyl)butan-1-amine1FMJ6D8Y1BMDL-72,974DTXSID508696294-fluoro-beta-(fluoromethylene)benzenebutanamineBenzenebutanamine, 4-fluoro-beta-(fluoromethylene)-, (E)-mofegilinumRefChem:159306DTXCID701526903
Weitere Namen anzeigen
MDL-729744-Fluoro-β-[(E)-fluoromethylene]benzenebutan-1-amine(E)-2-(Fluoromethylene)-4-(4-fluorophenyl)butan-1-amine(E)-2-(Fluoromethylene)-4-(4-fluorophenyl)-1-butanamineBenzenebutanamine, 4-fluoro-β-(fluoromethylene)-, (βE)-
Mofegiline [INN](E)-2-(Fluoromethylene)-4-(p-fluorophenyl)butylamineCHEMBL489079Mofegiline (free base)UNII-1FMJ6D8Y1BMDL 72974MOFEGILINE [MI]GTPL9754
Datenbank-Bezeichner
- CAS
119386-96-8- PubChem CID
- 6437850
- DTXSID
Eigenschaften
Berechnete StruktureigenschaftenWird ergänzt
- XLogP
- 2,3
- Polarare Oberfläche (TPSA)
- 26 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 3
- Frei drehbare Bindungen
- 4
- Schwere Atome
- 14
- Formalladung
- 0
- Komplexität
- 184
Chemie und Industrie
Pharmakologische Informationen
MeSH Pharmacological Classification
Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists.
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.
A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414)
Anwendungen
VerwendenAntiparkinsonian.
Anbieter1 Anbieter
AFINE CHEMICALS LIMITED+86-571-85134551 +86-18958018566 · [email protected]
Zugehörige Reaktionen
10
Notizen zur Verbindung
Wird geladen…